本文選題：膀胱尿道吻合術(shù) + 腹腔鏡檢查��； 參考：《北京大學(xué)學(xué)報(醫(yī)學(xué)版)》2017年02期

【摘要】：正前列腺癌是世界范圍內(nèi)男性的第二大癌癥死因,而前列腺癌根治術(shù)已成為局限性前列腺癌治療的金標準。隨著腹腔鏡和機器人技術(shù)的發(fā)展,腹腔鏡前列腺癌根治術(shù)(laparoscopic radical prostatectomy,LRP)或機器人輔助根治性前列腺切除術(shù)(robot-assisted radical prostatectomy,RARP)已經(jīng)成為主要的治療方式[1-3]。盡管國內(nèi)較大的醫(yī)院能夠
[Abstract]:Positive prostate cancer is the second leading cause of death in men worldwide, and radical prostatectomy has become the gold standard for the treatment of localized prostate cancer. With the development of laparoscopy and robotics, laparoscopic radical prostatectomy (laparoscopic radical prostatectomyrp) or robot-assisted radical prostatectomy (robot-assisted radical prostatectomy) have become the main treatment methods [1-3]. Although the larger hospitals in the country are able to
【作者單位】： 北京大學(xué)第三醫(yī)院泌尿外科;
【分類號】：R737.25
，

本文編號：2066312